Location History:
- Remagen-Oberwinter, DE (2015)
- Bonn, DE (2017)
Company Filing History:
2 out of 5 
2 out of 30 
1 out of 3 Years Active: 2015-2017
Title: Björn Scheffler: Innovator in Cancer Treatment
Introduction
Björn Scheffler is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Scheffler is recognized for his work in developing therapeutic methods for treating solid tumors and glioblastoma.
Latest Patents
One of Scheffler's latest patents focuses on "Niclosamide and its derivatives for use in the treatment of solid tumors." This invention explores novel therapeutic uses of niclosamide, particularly in combination with an alkylating agent for treating solid tumors characterized by underexpression of NFKBIA. Additionally, it includes diagnostic methods to determine the suitability of niclosamide treatment for cancer patients. Another significant patent is related to "Glioblastoma inhibiting compounds and their use," which involves gambogic acid amid and its derivatives for treating glioblastoma. This patent also discloses methods for assessing the appropriateness of these compounds for patients.
Career Highlights
Scheffler has worked with prominent organizations, including Life & Brain GmbH and Rheinische Friedrich-Wilhelms-Universität Bonn. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Martin Glas and Anja Wieland. Their collaborative efforts have further enhanced the impact of Scheffler's inventions in the field of cancer research.
Conclusion
Björn Scheffler's innovative work in cancer treatment exemplifies the importance of research and development in medical science. His patents reflect a commitment to improving therapeutic options for patients facing challenging diagnoses.